
Truveta brand logo mark in teal on a black background, featuring stacked chevron shapes forming the Truveta symbol.
Close

December 8 | 1pm ET / 10am PT

When evidence meets everyday care

A new view for medical affairs

Approval, publication, and guideline updates do not automatically translate into consistent patient care. Medical affairs leaders need a clearer view of what happens next: which patients receive treatment, where care differs from evidence, how treatment patterns evolve, and what clinical factors may be driving those decisions.

Join Truveta for a discussion of how current, clinically detailed real-world data can help medical affairs teams connect evidence with practice. The webinar will explore approaches for identifying care and evidence gaps, understanding treatment initiation, persistence, switching and discontinuation, and focusing scientific education and engagement on the populations where it may make the greatest difference.

Register for the webinar now

Professional headshot of a smiling person wearing blue-framed glasses, a checkered shirt, and a dark sweater against a gray background.

Speaker bios

Ryan Ahern, MD, MPH

Ryan Ahern, MD, MPH, interim co-CEO, Chief Medical Officer, and co-founder of Truveta, has more than a decade of experience in healthcare data and clinical research. At Truveta, he leads the Life Science Partner team, focused on developing new partnerships and ensuring partners are successful in their research. Prior to Truveta, he was Head of Corporate Development and Data Strategy at Clarify Health Solutions and an Engagement Manager in the Healthcare Strategy and Corporate Finance Practice at McKinsey & Company. Ryan is a Clinical Assistant Professor of Medicine at the University of Washington School of Medicine and practices at Harborview Medical Center.
Professional headshot of a man with gray hair and a trimmed beard, wearing a dark jacket and light blue shirt against a dark background.

Johnathan Lancaster, MD, PhD

Johnathan Lancaster, MD, PhD, President and Chief Scientific Officer at Truveta, leads the company’s Research, Partnerships, and Ecosystem teams. Prior to Truveta, he served as Senior Vice President and Head of Global Medical Affairs at Regeneron and was the Global Chief Medical Officer at Myriad Genetics. He spent more than a decade at Moffitt Cancer Center as a gynecologic oncologist, translational researcher, Chair of Women’s Oncology, and President of the Moffitt Medical Group. A pioneer in cancer genomics and personalized medicine, he has authored more than 100 peer-reviewed publications and holds eight patents in cancer detection and therapeutics.